首页> 外文期刊>Current computer-aided drug design >Post-Docking Optimization and Analysis of Protein-Ligand Interactions of Estrogen Receptor Alpha using AMMOS Software
【24h】

Post-Docking Optimization and Analysis of Protein-Ligand Interactions of Estrogen Receptor Alpha using AMMOS Software

机译:使用AMMOS软件对接后优化和雌激素受体α的蛋白配体相互作用

获取原文
获取原文并翻译 | 示例
           

摘要

In silico approaches have gained immense significance in the recent years and have become an integral part of research in both, academic institutions and different industry branches, thus assisting drug design and discovery. Among these methods the virtual ligand screening (VLS) of bioactive compounds has been established as an effective approach to handle large sets of compounds improving in this way the "hit-rate" of drug discovery programs [1-3]. Structure-based VLS (SB-VLS) relies on the three dimensional structure of the biological target obtained either through experimental methods such as X-ray crystallography or NMR spectroscopy [4], or predicted by homology modeling. Most of the SB-VLS protocols [5-7] employ docking of all compounds in an appropriate chemical library into the binding pocket of the selected target and evaluate the fit between the molecules via scoring functions. Critical for docking accuracy is the treatment of the ligand flexibility and, in many cases, the receptor flexibility [8-10], the last increasing considerably the computational time. It is impractical to perform SB-VLS using docking on a fully flexible protein receptor for a large number of ligands. It has been shown that post-docking optimization, either after conventional docking-scoring procedures or after hierarchical VLS protocols [6, 11, 12] helps in improving both, the docking pose and the scoring, and thus the overall efficiency of SB-VLS. This view is supported by a number of examples of binding pose prediction and enrichment improvements after post-docking energy minimization [13-17].
机译:近年来,计算机方法已经变得非常重要,并且已成为学术机构和不同行业分支研究的组成部分,从而有助于药物设计和发现。在这些方法中,已经建立了生物活性化合物的虚拟配体筛选(VLS)作为处理大量化合物的有效方法,以这种方式提高了药物发现程序的“命中率” [1-3]。基于结构的VLS(SB-VLS)依赖于通过诸如X射线晶体学或NMR光谱等实验方法获得的或通过同源性建模预测的生物靶标的三维结构。大多数SB-VLS协议[5-7]都将适当化学文库中的所有化合物对接到所选靶标的结合袋中,并通过评分功能评估分子之间的适合度。对接精度的关键是配体柔韧性的处理,在许多情况下,受体柔韧性的处理[8-10],最后一次显着增加了计算时间。使用对接于大量配体的完全柔性的蛋白质受体来执行SB-VLS是不切实际的。已经显示,在传统的对接评分程序之后或在分层VLS协议之后,对接后优化都有助于改善对接姿势和评分,从而改善SB-VLS的整体效率。停靠后能量最小化后,绑定姿势预测和富集改进的许多示例均支持此观点[13-17]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号